These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15458929)

  • 1. Breast cancer.
    American College of Obstetricians and Gynecologists Women's Health Care Physicians
    Obstet Gynecol; 2004 Oct; 104(4 Suppl):11S-16S. PubMed ID: 15458929
    [No Abstract]   [Full Text] [Related]  

  • 2. Alcohol use, with hormone therapy, may increase breast cancer risk.
    Mayo Clin Womens Healthsource; 2006 May; 10(5):3. PubMed ID: 16585921
    [No Abstract]   [Full Text] [Related]  

  • 3. Thoughts around the ridges.
    Colquhoun JP
    Aust Fam Physician; 1996 Oct; 25(10):1643-4. PubMed ID: 8936746
    [No Abstract]   [Full Text] [Related]  

  • 4. Progesterone, progestins, pregnancy and breast cancer risk.
    Ferretti G
    Breast Cancer Res Treat; 2007 Jul; 103(3):373-4. PubMed ID: 17063269
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hormone replacement therapy and cancer risk].
    Nierwetberg D; Schmidt M; Kimmig R
    MMW Fortschr Med; 2008 Oct; 150(43):27-8. PubMed ID: 19031580
    [No Abstract]   [Full Text] [Related]  

  • 6. Controversies over hormone replacement therapy. HRT as a risk factor of breast cancer in postmenopausal women.
    Licznerska BE; Baer-Dubowska W
    Acta Pol Pharm; 2005; 62(3):241-7. PubMed ID: 16193819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More on breast cancer guidelines.
    Reid RL
    CMAJ; 1998 Jun; 158(11):1426; author reply 1429-30. PubMed ID: 9629097
    [No Abstract]   [Full Text] [Related]  

  • 8. Directly comparing routes of administration and types of hormone therapy on risk markers for breast cancer.
    Pru JK
    Menopause; 2007; 14(4):611. PubMed ID: 17471109
    [No Abstract]   [Full Text] [Related]  

  • 9. [Estrogen replacement therapy and breast cancer].
    Zahl PH; Maehlen J
    Tidsskr Nor Laegeforen; 2005 Apr; 125(8):1045; author reply 1045. PubMed ID: 15852091
    [No Abstract]   [Full Text] [Related]  

  • 10. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast cancer risk factors. The latest facts, your best means of defense.
    Mayo Clin Womens Healthsource; 2007 Oct; 11(10):1-2. PubMed ID: 18418906
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
    Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
    Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormones and breast cancer: should practice be changed?
    Collins J
    Obstet Gynecol; 2006 Dec; 108(6):1352-3. PubMed ID: 17138765
    [No Abstract]   [Full Text] [Related]  

  • 14. Is hormone replacement therapy-related breast cancer more favorable? A case-control study.
    Khan HN; Bendall S; Bates T
    Breast J; 2007; 13(5):496-500. PubMed ID: 17760672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy for breast cancer survivors: an answered question?
    Zielinski SL
    J Natl Cancer Inst; 2005 Jul; 97(13):955. PubMed ID: 15998945
    [No Abstract]   [Full Text] [Related]  

  • 16. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.
    Bernstein L
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):288-96. PubMed ID: 16611204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What about breast cancer and cardiovascular disease risks with the best treatments during the climacterium and beyond.
    Neves-e-Castro M
    Gynecol Endocrinol; 2005 Jun; 20(6):301-4. PubMed ID: 16019377
    [No Abstract]   [Full Text] [Related]  

  • 18. [Alarming data on the risk of breast cancer following estrogen replacement therapy should be interpreted carefully].
    Odlind V
    Lakartidningen; 2005 Apr 18-24; 102(16):1217-8. PubMed ID: 15921094
    [No Abstract]   [Full Text] [Related]  

  • 19. What is new in breast cancer? The expanding role of aromatase inhibitors.
    Hakulinen T; Untch M; Farmer R;
    Gynecol Endocrinol; 2006 Jun; 22 Suppl 2():1-13. PubMed ID: 17048352
    [No Abstract]   [Full Text] [Related]  

  • 20. [Is estrogen replacement therapy contraindicated in breast cancer?].
    Iversen OE
    Tidsskr Nor Laegeforen; 2006 Feb; 126(5):611-2. PubMed ID: 16505873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.